World Pharma News Digest - 18.03.2008 (with web links)

Public consultation in preparation of a legal proposal to combat
counterfeit medicines for human use
Counterfeiting of medicinal products has become an increasing threat
for patients, healthcare professionals and industry and a concern for
EU and national policy-makers. The Directorate-General Enterprise and
Industry is consulting all stakeholders and interested parties on key
ideas for amending the regulatory framework for medicinal products in
an effort to combat the counterfeiting of medicinal products.
Read more...
* w w w .worldpharmanews . com /content/view/339/1/

FDA Takes Next Step in Establishing Overseas Presence
In an important development, the U.S. Food and Drug Administration has
received approval from the U.S. State Department to establish eight
full time permanent FDA positions at U.S. diplomatic posts in the
People's Republic of China, pending authorization from the Chinese
government.
Read more...
* w w w .worldpharmanews . com /content/view/338/1/

GSK statement on MHRA investigation
GlaxoSmithKline (GSK) notes the conclusions announced by the Medicines
and Healthcare products Regulatory Agency (MHRA) regarding its
investigation into disclosure of paediatric trial data for the anti-
depressant medicine Seroxat (paroxetine).
Read more...
* w w w .worldpharmanews . com /content/view/337/1/

First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary
Stent
Data published in The Lancet from ABSORB, the world's first clinical
trial of a fully bioabsorbable drug eluting stent for the treatment of
coronary artery disease, demonstrated no stent thrombosis, no
clinically driven target lesion revascularizations (retreatment of a
diseased lesion), and a low (3.3 percent) rate of major adverse
cardiac events (MACE) in 30 patients out to one year.
Read more...
* w w w .worldpharmanews . com /content/view/336/1/

FDA Issues Alert on Tussionex, a Long-Acting Prescription Cough
Medicine Containing Hydrocodone
The U.S. Food and Drug Administration issued an alert today on the
safe and correct use of Tussionex Pennkinetic Extended-Release
Suspension in response to numerous reports of adverse events -
including death - associated with the misuse and inappropriate use of
this potent cough medication.
Read more...
* w w w .worldpharmanews . com /content/view/335/1/

World Pharma News . net /Published News:

FDA Takes Next Step in Establishing Overseas Presence
* w w w .worldpharmanews . net /Research_Development/FDA_Takes_Next_Step_in_Establishing_Overseas_Presence/

Cheminfostream: Bursary Award for Drug Discovery Training Week in
Oxford
* w w w .worldpharmanews . net /Conferences_Events/Cheminfostream_Bursary_Award_for_Drug_Discovery_Training_Week_in_Oxford/

Pharmalot Bayer Uses CME To Stop The Trasylol Bleeding
* w w w .worldpharmanews . net /Blogs/Pharmalot_-_Bayer_Uses_CME_To_Stop_The_Trasylol_Bleeding/

GSK statement on MHRA investigation
* w w w .worldpharmanews . net /Corporate/GSK_statement_on_MHRA_investigation/

Pharmalot A Soap Opera: Pharmaceuticals Is An Ugly Business
* w w w .worldpharmanews . net /Blogs/Pharmalot_-_A_Soap_Opera_Pharmaceuticals_Is_An_Ugly_Business/

Pharmalot A Heparin Tale: Dennis Quaid On 60 Minutes
* w w w .worldpharmanews . net /Blogs/Pharmalot_-_A_Heparin_Tale_Dennis_Quaid_On_60_Minutes/

Trends in Health 2.0: Mark Bard - Manhattan Research
* w w w .worldpharmanews . net /Blogs/Trends_in_Health_2-0_Mark_Bard_-_Manhattan_Research/

First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary
Stent
* w w w .worldpharmanews . net /ClinicalTrials/First_Clinical_Trial_of_a_Fully_Bioabsorbable_Drug_Eluting_Coronary_Stent/

Amgen, JNJ Get Somewhat Mixed Message From FDA Panel - MSNBC . com
* w w w .worldpharmanews . net /Blogs/Amgen_JNJ_Get_Somewhat_Mixed_Message_From_FDA_Panel__-_MSNBC-com/

CNTO411 Employee Blogging and Other Comments worth Responding toa4
* w w w .worldpharmanews . net /Blogs/CNTO411_-_Employee_Blogging_and_Other_Comments_worth_Responding_tohellip/